PB1980: ASC4KIDS: A MULTICENTER, OPEN-LABEL, PHASE 1B/2 STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

• Nobuko Hijiya,
• Shruti Kapoor,
• Matthias Hoch,
• Laurence Descamps,
• Kohinoor Dasgupta,
• Ana Paula Torres Cardoso

Affiliations

Nobuko Hijiya

1 Columbia University Irving Medical Center, Pediatric Hematology Oncology and Stem Cell Transplant, New York, United States

Shruti Kapoor

2 Novartis Pharmaceuticals Corporation, East Hanover, United States

Matthias Hoch

3 Novartis Institute for BioMedical Research, Basel, Switzerland

Laurence Descamps

4 Novartis Pharma SAS, Rueil-Malmaison, France, France

Kohinoor Dasgupta

5 Novartis Healthcare Pvt. Ltd, Hyderabad, India

Ana Paula Torres Cardoso

2 Novartis Pharmaceuticals Corporation, East Hanover, United States